About Biogenomics Limited
Data last updated: 05 January 2026
Biogenomics Limited is a public limited company based in Pondicherry, Pondicherry, India, a subsidiary of Mb Holdings Mauritius Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 April 2002, the company has been in operation for over 24 years.
Registered with ROC Pondicherry under CIN U24234PY2002PLC009158.
Capital: an authorised share capital of ₹390.02 Cr and a paid-up capital of ₹383.51 Cr. Formerly known as Biogenomics Private Limited. It is led by directors including Pushkar Jauhari and Rajesh Shashikant Dalal.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: R. S. No. 139 Manapet Road Kanniakoil Manapet Village, Bahour Commune Pondicherry, Pondicherry, India – 607402.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.42 Cr, a growth of 25.48% compared to the previous year.
The company has a workforce of approximately 193 employees as per the latest available data. It operates as a subsidiary of Mb Holdings Mauritius Limited.
The company is associated with 2 brands - Aurisignum, Biogenomics. As per MCA filings, the company has open charges of ₹3.98 Cr and satisfied charges of ₹8.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biogenomics.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressR. S. No. 139 Manapet Road Kanniakoil Manapet Village, Bahour Commune Pondicherry, Pondicherry, India – 607402
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Biogenomics Limited
Biogenomics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24234PY2002PLC009158, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24234PY2002PLC009158 | Current |
| L24234TN2002PLC048821 | Previous |
| U24234TN2002PLC048821 | Previous |
Associated Brands with Biogenomics Limited
Biogenomics Limited operates two associated brands: AuriSignum and BioGenomics. These brands represent Biogenomics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers characterization services for biopharmaceuticals including proteins and antibodies. | aurisignum.com | |
| Recombinant DNA-based biosimilars, proteins, and enzymes are developed. | biogenomics.co.in |
Competitors & Alternatives of Biogenomics Limited
Brands and companies operating in the same space as Biogenomics Limited include Moderna, Jazz Pharmaceuticals, Advanced Accelerator Applications and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Moderna
|
mRNA-based therapeutics for diseases including cancer and infections are developed. | Cambridge, United States, United States | 2010 |
Jazz Pharmaceuticals
|
Novel biopharmaceutical medicines are developed for unmet medical needs. | Dublin, Ireland, Ireland | 2003 |
Advanced Accelerator Applications
|
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | Saint Genis Pouilly, France, France | 2002 |
C4 Therapeutics
|
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | Cambridge, United States, United States | 2016 |
BeiGene
|
Targeted and immune-oncology drugs for cancer treatment are developed. | Cambridge, United States, United States | 2010 |
Syndax
|
Targeted therapies for cancer treatment are developed. | Waltham, United States, United States | 2005 |
Revolution Medicines
|
Cancer therapies are developed using selective pathway inhibitors. | Redwood City, United States, United States | 2014 |
Blueprint Medicines
|
Selective kinase inhibitors are developed for genomically defined cancers. | Cambridge, United States, United States | 2008 |
Incyte
|
Small molecules are developed for cancer and skin disease treatments. | Wilmington, United States, United States | 1991 |
Alderley Analytical
|
Bioanalytical assays for drug development are developed and validated. | Stockport, United Kingdom, United Kingdom | 2013 |
Business Activity of Biogenomics Limited
Biogenomics Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Biogenomics Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Biogenomics Limited
Biogenomics Limited is audited by S R B C & CO LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & CO LLP | Locked | Locked | Locked |
Complete auditor history for Biogenomics Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biogenomics Limited
Biogenomics Limited is currently managed by 9 directors, with 22 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pushkar Jauhari
Also directs:
Jupiter International Limited, Coreel Technologies (India) Private Limited, Rentomojo Private Limited and 1 more
|
Nominee Director | 19 Jun 2022 | 4 Years 1 Months | Current |
| Rajesh Shashikant Dalal | Director | 08 Dec 2023 | 2 Years 8 Months | Current |
| Rajiv Malik | Additional Director | 01 Jul 2025 | 1 Years 1 Months | Current |
| Namit Rustagi | Director | 28 Mar 2022 | 4 Years 4 Months | Current |
| Ammar Abdullah Hamad Al Ali | Director | 28 Mar 2022 | 4 Years 4 Months | Current |
|
Archana Rajesh Krishnan
Also directs:
Reflex Technologies Private Limited
|
Whole-Time Director | 03 Feb 2006 | 20 Years 6 Months | Current |
Financials of Biogenomics Limited FY 2025 filings available
Biogenomics Limited reported revenue of ₹13.42 Cr (up 25.48% YoY) for FY 2024.
Ten-year financial statements for Biogenomics Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Biogenomics Limited
Shareholding and ownership data for Biogenomics Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biogenomics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | Standard Chartered Bank | ₹3.98 Cr | Satisfied |
| 11 Jan 2014 | Icici Bank Limited | ₹3.6 Cr | Satisfied |
| 10 Oct 2003 | U.C.O. Bank | ₹1.12 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Biogenomics Limited
Biogenomics Limited has a workforce of 193 employees as of Dec 02, 2024.
Employee and EPFO history for Biogenomics Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Biogenomics Limited
GST registrations and filing compliance for Biogenomics Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Biogenomics Limited
Credit ratings, litigation, and regulatory alerts for Biogenomics Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biogenomics Limited
MSME payment history for Biogenomics Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biogenomics Limited
Corporate group structure for Biogenomics Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biogenomics Limited
MCA filings and documents for Biogenomics Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Biogenomics Limited
Frequently Asked Questions about Biogenomics Limited
Biogenomics Limited is an active public limited company in the pharma sector based in Pondicherry, Pondicherry, India. It was incorporated on 24 April 2002 (24+ years old) and is registered under CIN U24234PY2002PLC009158. The company has 193 employees.
Biogenomics Limited reported revenue of ₹13.42 Cr for FY 2024 (up 25.48% YoY).
The current directors of Biogenomics Limited are:
- Pushkar Jauhari - Nominee Director
- Rajesh Shashikant Dalal - Director
- Rajiv Malik - Additional Director
- Namit Rustagi - Director
- Ammar Abdullah Hamad Al Ali - Director
- Archana Rajesh Krishnan - Whole-Time Director
- Imran Jamiluddin Shaikh - Nominee Director
- Ali Abdullah Ali Al Aamri - Nominee Director
- Mohammed Hamdan Saif Al Rubaie - Nominee Director
The primary industry of Biogenomics Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Biogenomics Limited can be reached at the registered office: R. S. No. 139 Manapet Road Kanniakoil Manapet Village, Bahour Commune Pondicherry, Pondicherry, India – 607402, or through the website biogenomics.co.in.
The authorised capital is ₹390.02 Cr, and the paid-up capital is ₹383.51 Cr.